Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
STAR | BSE
26.30
5.42%
Healthcare
Drug Manufacturers-Specialty & Generic
30/09/2023
08/12/2023
511.60
486.20
514.55
486.20
Strides Pharma Science Limited develops manufactures and sells pharmaceutical products in Africa Australia North America Europe Asia India and internationally. It operates through two segments Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms such as tablets hard and soft gelatin capsules sachets and liquids as well as nasal spray powders solids ointments and creams. It also develops branded generics products for the treatment of chronic therapies including women's health central nervous system cardiovascular diabetes dermatology and probiotics under the Renerve Unibrol Combiart Duotab and Vitafer brands; and anti-retroviral anti-malarial anti-tuberculosis Hepatitis and other infectious disease drug segments for institutional business. The company has a strategic partnership with Orbicular Pharmaceutical Technologies Private Limited to develop manufacture and commercialize nasal sprays. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru India.
View LessPositive Momentum
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Smallcap (300M - 2B USD)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
36.3%1 month
28.0%3 months
37.2%6 months
38.0%0
0
2.17
1.36
0.44
27.31
1.85
0
5.02B
46.98B
563.27M
0.30
9.31
-36.80
11.40
-11.86
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
40.50
Range1M
50.00
Range3M
96.25
Rel. volume
1.78
Price X volume
16.94M